polyuria

多尿
  • 文章类型: Journal Article
    背景:肾功能降低会损害盐和水的稳态,可以驱动夜间或24小时多尿。夜尿症可以在慢性肾脏疾病(CKD)的早期出现。基于证据的建议可以促进肾病诊所以外的管理。
    目的:对CKD患者的夜尿症进行系统评价(SR),并就肾脏病以外的初级保健和专科诊所的管理达成专家共识。
    方法:从2000年1月至2020年4月检索了四个数据库。共筛选了4011篇标题和摘要,108项研究进行了全文筛选。七项研究符合纳入标准,两项通过其他来源确定。使用名义小组技术(NGT)在公众参与的专家小组之间达成了共识。
    结果:一些可能的机制导致CKD患者夜间或24小时多尿,但是关于改善夜尿症的干预措施的证据很少。对于CKD患者或在非肾脏病环境中评估有CKD风险的患者的夜尿症(每晚至少两次空洞)的NGT评估建议是:病史(口渴,液体摄入量),药物审查(利尿剂,锂,钙通道拮抗剂,非甾体抗炎药),检查(水肿状态,血压),尿液分析(血尿和白蛋白/肌酐比率),血液检查(血尿素,血清肌酐和电解质,估计的肾小球滤过率),还有膀胱日记.肾脏超声检查应遵循当地CKD指南。治疗方案包括优化血压控制,饮食调整,以减少盐的摄入量,流体建议,和药物审查。转诊专科肾脏病服务应遵循当地指南。
    结论:在评估夜尿症患者时,应考虑CKD。评估的目的是确定机制和鼓励治疗,但后者可能比夜尿症本身更适用于降低与CKD相关的更广泛的发病率。
    结果:患有肾脏疾病的人可能会因为需要通尿过夜而遭受严重的睡眠障碍。我们查看了已发表的研究,发现了一些有关潜在机制的有用信息。一组专家能够开发评估和治疗这种情况的实用方法。
    BACKGROUND: Reduced renal function impairs salt and water homeostasis, which can drive nocturnal or 24-h polyuria. Nocturia can arise early in chronic kidney disease (CKD). Evidence-based recommendations can facilitate management outside nephrology clinics.
    OBJECTIVE: To conduct a systematic review (SR) of nocturia in CKD and achieve expert consensus for management in primary care and in specialist clinics outside nephrology.
    METHODS: Four databases were searched from January 2000 to April 2020. A total of 4011 titles and abstracts were screened, and 108 studies underwent full-text screening. Seven studies met the inclusion criteria and two were identified through other sources. Consensus was achieved among an expert panel with public involvement using the nominal group technique (NGT).
    RESULTS: Several plausible mechanisms contribute to nocturnal or 24-h polyuria in CKD, but there is little evidence on interventions to improve nocturia. NGT assessment recommendations for nocturia (at least two voids per night) in patients with CKD or at risk of CKD being assessed in a non-nephrology setting are: history (thirst, fluid intake), medication review (diuretics, lithium, calcium channel antagonists, nonsteroidal anti-inflammatory medications), examination (oedematous state, blood pressure), urinalysis (haematuria and albumin/creatinine ratio), blood tests (blood urea, serum creatinine and electrolytes, estimated glomerular filtration rate), and a bladder diary. Renal ultrasound should follow local CKD guidelines. Treatment options include optimising blood pressure control, dietary adjustment to reduce salt intake, fluid advice, and a medication review. Referral to specialist nephrology services should follow local guidelines.
    CONCLUSIONS: CKD should be considered when evaluating patients with nocturia. The aim of assessment is to identify mechanisms and instigate therapy, but the latter may be more applicable to reducing wider morbidity associated with CKD than nocturia itself.
    RESULTS: People with kidney disease can suffer severe sleep disturbance because of a need to pass urine overnight. We looked at published research and found some useful information about the underlying mechanisms. A group of experts was able to develop practical approaches for assessing and treating this condition.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:盐和水的体内平衡受激素调节,因此,多尿可以直接或通过继发性作用由内分泌疾病引起。这些机制在夜尿症的初级保健管理中并未得到一致考虑。
    目的:进行内分泌疾病夜尿症的系统评价(SR),并达成初级保健管理专家共识。
    方法:从2000年1月至2020年4月检索了四个数据库。总共筛选了4382个标题和摘要,36项研究进行了全文筛选,14项研究纳入分析.专家和公众的共识是使用名义组技术(NGT)。
    结果:12项研究集中在夜尿症的机制上,虽然两种治疗方案进行了评估,但没有一项研究是在初级医疗机构进行的。NGT共识确定了关键的临床评估主题,包括口渴的存在,糖尿病或尿崩症的医学背景,甲状腺疾病,雌激素状态,药物(液体流失或口干),和包括体重指数在内的一般检查。建议的调查包括膀胱日记,肾和甲状腺功能,钙,和糖化血红蛋白.尽管有液体建议,但在多尿>2.5l/24h持续的情况下,应检查晨尿渗透压。限制液体后尿液浓度>600mOsm/l,不包括尿崩症。治疗应该包括教育,在可能的情况下,包括调整生活方式和药物治疗。任何潜在的内分泌疾病应根据当地指导进行管理。如果有甲状腺功能亢进,需要转诊到内分泌科,甲状旁腺功能亢进,或早晨尿液渗透压<600mOsm/l后过夜液体避免。
    结论:内分泌疾病可通过不同的盐和水调节途径导致夜尿症。管理的目的是识别和处理致病因素,但副作用会限制夜尿症的改善。
    结果:荷尔蒙功能改变的人可能会因为控制水和盐水平的问题而需要通过尿液而遭受严重的睡眠障碍。一个专家小组根据现有的少量最新发表的研究,建议了评估和治疗这些问题的最佳方法。
    BACKGROUND: Salt and water homeostasis is regulated hormonally, so polyuria can result from endocrine disease directly or via secondary effects. These mechanisms are not consistently considered in primary care management of nocturia.
    OBJECTIVE: To conduct a systematic review (SR) of nocturia in endocrine disease and reach expert consensus for primary care management.
    METHODS: Four databases were searched from January 2000 to April 2020. A total of 4382 titles and abstracts were screened, 36 studies underwent full-text screening, and 14 studies were included in the analysis. Expert and public consensus was achieved using the nominal group technique (NGT).
    RESULTS: Twelve studies focused on mechanisms of nocturia, while two evaluated treatment options; none of the studies took place in a primary care setting. NGT consensus identified key clinical evaluation themes, including the presence of thirst, a medical background of diabetes mellitus or insipidus, thyroid disease, oestrogen status, medications (fluid loss or xerostomia), and general examination including body mass index. Proposed investigations include a bladder diary, renal and thyroid function, calcium, and glycated haemoglobin. Morning urine osmolarity should be examined in the context of polyuria of >2.5 l/24 h persisting despite fluid advice, with urine concentration >600 mOsm/l after fluid restriction excluding diabetes insipidus. Treatment should involve education, including adjustment of lifestyle and medication where possible. Any underlying endocrine disorder should be managed according to local guidance. Referral to endocrinology is needed if there is hyperthyroidism, hyperparathyroidism, or morning urine osmolarity <600 mOsm/l after overnight fluid avoidance.
    CONCLUSIONS: Endocrine disease can result in nocturia via varied salt and water regulation pathways. The aim of management is to identify and treat causative factors, but secondary effects can restrict improvements in nocturia.
    RESULTS: People with altered hormone function can suffer from severe sleep disturbance because of a need to pass urine caused by problems in controlling water and salt levels. An expert panel recommended the best ways to assess and treat these problems on the basis of the rather small amount of up-to-date published research available.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Journal Article
    Nocturia is a common bothersome condition. An ad hoc group of interested clinicians from a variety of backgrounds has developed draft guidelines for the assessment and management of this condition in primary care in New Zealand. The guidelines propose four steps in the assessment and management: clinical evaluation; simple investigations; assignment of a provisional diagnosis; and management based on the provisional diagnosis. For nocturnal polyuria-associated nocturia, the draft guidelines recommend that: lifestyle measures should be used as part of the management; if a patient complaining of nocturia has other features of overactive bladder, then bladder retraining and/or anticholinergics can be used; hypnosedatives should not be used to treat nocturia in older adults because of the increased risk of falls; loop diuretics given in the afternoon should be considered for the treatment; and desmopressin can be considered in the management of nocturnal polyuria associated nocturia but that it should be used cautiously in people aged over 65 because of the risk of hyponatraemia. A draft algorithm based on international guidelines is presented.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号